Arne Christians

Carl Neuberg Str. 1
Hannover, NI 30625, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

EMP3 sustains oncogenic EGFR/CDK2 signaling by restricting receptor degradation in glioblastoma.

EMP3 sustains oncogenic EGFR/CDK2 signaling by restricting receptor degradation in glioblastoma.

Journal: Acta neuropathologica communications

Published: April 18, 2023

Multiplexed imaging and automated signal quantification in formalin-fixed paraffin-embedded tissues by ChipCytometry.

Multiplexed imaging and automated signal quantification in formalin-fixed paraffin-embedded tissues by ChipCytometry.

Journal: Cell reports methods

Published: April 26, 2021

In-Depth Immune-Oncology Studies of the Tumor Microenvironment in a Humanized Melanoma Mouse Model.

In-Depth Immune-Oncology Studies of the Tumor Microenvironment in a Humanized Melanoma Mouse Model.

Journal: International journal of molecular sciences

Published: December 30, 2020

Rare heterozygous GDF6 variants in patients with renal anomalies.

Rare heterozygous GDF6 variants in patients with renal anomalies.

Journal: European journal of human genetics : EJHG

Published: March 20, 2020

The prognostic role of IDH mutations in homogeneously treated patients with anaplastic astrocytomas and glioblastomas.

The prognostic role of IDH mutations in homogeneously treated patients with anaplastic astrocytomas and glioblastomas.

Journal: Acta neuropathologica communications

Published: August 07, 2019

Characterization of the epithelial membrane protein 3 interaction network reveals a potential functional link to mitogenic signal transduction regulation.

Characterization of the epithelial membrane protein 3 interaction network reveals a potential functional link to mitogenic signal transduction regulation.

Journal: International journal of cancer

Published: July 05, 2018

Cerebellar glioblastoma: a clinical series with contemporary molecular analysis.

Cerebellar glioblastoma: a clinical series with contemporary molecular analysis.

Journal: Acta neurochirurgica

Published: May 30, 2018

Absence of MGMT promoter methylation in diffuse midline glioma, H3 K27M-mutant.

Absence of MGMT promoter methylation in diffuse midline glioma, H3 K27M-mutant.

Journal: Acta neuropathologica communications

Published: November 24, 2017

Rare ADAR and RNASEH2B variants and a type I interferon signature in glioma and prostate carcinoma risk and tumorigenesis.

Rare ADAR and RNASEH2B variants and a type I interferon signature in glioma and prostate carcinoma risk and tumorigenesis.

Journal: Acta neuropathologica

Published: June 21, 2017

Frequency of BRAF V600E mutations in 969 central nervous system neoplasms.

Frequency of BRAF V600E mutations in 969 central nervous system neoplasms.

Journal: Diagnostic pathology

Published: April 05, 2016

Prognostic value of three different methods of MGMT promoter methylation analysis in a prospective trial on newly diagnosed glioblastoma.

Prognostic value of three different methods of MGMT promoter methylation analysis in a prospective trial on newly diagnosed glioblastoma.

Journal: PloS one

Published: October 12, 2011

No prognostic value of IDH1 mutations in a series of 100 WHO grade II astrocytomas.

No prognostic value of IDH1 mutations in a series of 100 WHO grade II astrocytomas.

Journal: Journal of neuro-oncology

Published: September 26, 2011

Showing 1-12 of 12

Last Updated: 09/26/2026